NO SET ASIDE USED.

TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE - EO 14398 BAA TARGETED POLYMER-LIPID NANOPARTICLE PLATFORM FOR BIOPROTAC MEDIATED DEGRADATION OF ONCOFUSION PROTEINS IN EWING SARCOMA

PIID: 75F40126C00066Solicitation ID: FDABAA -26- 00123
Signed Date: Sep 24, 2026Effective Date: Sep 15, 2026End Date: Closes in 697 days
Award $
$2.7M
Vendor
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE
NAICS
541715
Signed Date
Sep 24, 2026

Key Details

Dollars Obligated
$2.7M
Base & All Options
$7.0M
Awarding Sub-Agency
Food and Drug Administration
Product Service Code
AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
257
Place of Performance
PHILADELPHIA, PA

Description

EO 14398 BAA TARGETED POLYMER-LIPID NANOPARTICLE PLATFORM FOR BIOPROTAC MEDIATED DEGRADATION OF ONCOFUSION PROTEINS IN EWING SARCOMA

Context & Analysis

On Sep 24, 2026, Department of Health and Human Services obligated $2,682,546 to TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE for eo 14398 baa targeted polymer-lipid nanoparticle platform for bioprotac mediated degradation of oncofusion proteins in ewing sarcoma. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition with 257 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PHILADELPHIA, PA. The contract is scheduled through Sep 23, 2028. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.

Contractor Information

UEI: GM1XX56LEP58
Location: PHILADELPHIA, PA

Stay Updated

Get notified about new opportunities matching your interests.

Related